Literature DB >> 34901175

Trichodynia Revisited.

Ralph M Trüeb1, Michela V R Starace2, Bianca Maria Piraccini2, Hudson Dutra Rezende3, Maria Fernanda Reis Gavazzoni Dias4.   

Abstract

Trichodynia refers to the painful sensation of the scalp related to the complaint of hair loss. Originally suggested to be distinguishing for telogen effluvium and related to hair loss activity and follicular inflammation, further studies have found trichodynia to be common in androgenetic alopecia as well and coexisting with psychopathologic findings. The respective studies failed to demonstrate correlations between trichodynia and quantifiable hair loss activity, nor histopathologic evidence for follicular inflammation. A symptomatic scalp is a frequent condition in specific dermatological conditions of the scalp. By definition of exclusion, we are not dealing with trichodynia in these cases. It is conceivable that neuropeptides are key players between the central nervous system and the skin immune and microvascular system. Such mechanisms would explain the noxious effects of both external stimuli and emotional distress in eliciting cutaneous nociception. Since we have begun to understand the diverse etiologies of trichodynia, and a single term does not measure up to this circumstance, it may be wiser to describe the condition depending on the type of scalp sensation and its specific disease association. Further studies are warranted into the neural/endothelial/follicular interactions both in hair growth and shedding and the psychosomatic diseases of the hair and scalp.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Botulinum toxin; Neuropeptide substance P; Scalp dysesthesia; Symptomatic scalp; Trichodynia

Year:  2021        PMID: 34901175      PMCID: PMC8613582          DOI: 10.1159/000517463

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  41 in total

1.  Diffuse alopecia in women. Its unexplained apparent increase in incidence.

Authors:  M B SULZBERGER; V H WITTEN; A W KOPF
Journal:  Arch Dermatol       Date:  1960-04

2.  The role of sleep in telogen effluvium and trichodynia: a commentary in the context of the current pandemic.

Authors:  Ellen M S Xerfan; Monica L Andersen; Anamaria S Facina; Sergio Tufik; Jane Tomimori
Journal:  J Cosmet Dermatol       Date:  2021-01-02       Impact factor: 2.696

3.  Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia.

Authors:  D A Whiting
Journal:  J Am Acad Dermatol       Date:  1993-05       Impact factor: 11.527

4.  Substance P (SP) in innervated and non-innervated blood vessels in the skin of patients with symptomatic scalp.

Authors:  M Ericson; A Gabrielson; S Worel; W S Lee; M K Hordinsky
Journal:  Exp Dermatol       Date:  1999-08       Impact factor: 3.960

5.  Scalp dysesthesia.

Authors:  D Hoss; S Segal
Journal:  Arch Dermatol       Date:  1998-03

6.  Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.

Authors:  Ninan T Mathew; Jayasree Kailasam; Lori Meadors
Journal:  Headache       Date:  2007-09-12       Impact factor: 5.887

7.  The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia.

Authors:  Ilknur Kivanç-Altunay; Canan Savaş; Gonca Gökdemir; Adem Köşlü; Eşber Baki Ayaydin
Journal:  Int J Dermatol       Date:  2003-09       Impact factor: 2.736

Review 8.  Telogen effluvium: a comprehensive review.

Authors:  Alfredo Rebora
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-08-21

9.  North American Virginian Witch Hazel (Hamamelis virginiana): Based Scalp Care and Protection for Sensitive Scalp, Red Scalp, and Scalp Burn-Out.

Authors:  Ralph M Trüeb
Journal:  Int J Trichology       Date:  2014-07

10.  Trichoscopy of scalp dysesthesia.

Authors:  Adriana Rakowska; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.